Phase I/II of Oral Vorinostat Combination With Erlotinib in NSCLC Patients With EGFR Mutations With DP After Erlotinib.
about
Phase I/II of Oral Vorinostat Combination With Erlotinib in NSCLC Patients With EGFR Mutations With DP After Erlotinib.
description
clinical trial
@en
klinisch onderzoek
@nl
name
Phase I/II of Oral Vorinostat ...... tions With DP After Erlotinib.
@en
type
label
Phase I/II of Oral Vorinostat ...... tions With DP After Erlotinib.
@en
prefLabel
Phase I/II of Oral Vorinostat ...... tions With DP After Erlotinib.
@en
P6153
P1476
Sequential Phase I/II Trial of ...... sion After Erlotinib Treatment
@en
P17
P3098
NCT00503971
P580
2007-12-01T00:00:00Z
P582
2008-12-01T00:00:00Z